Recent developments on the vascular effects of 20-hydroxyeicosatetraenoic acid

被引:22
|
作者
Garcia, Victor [1 ]
Schwartzman, Michal L. [2 ]
机构
[1] Yale Univ, Dept Pharmacol, New Haven, CT USA
[2] New York Med Coll, Sch Med, Dept Pharmacol, 15 Dana Rd, Valhalla, NY 10595 USA
来源
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION | 2017年 / 26卷 / 02期
关键词
cytochrome P450; endothelial dysfunction; hypertension; stroke; vascular remodeling; CYTOCHROME P450-DERIVED EICOSANOIDS; ANGIOTENSIN-CONVERTING ENZYME; SALT-SENSITIVE HYPERTENSION; PHOSPHOLIPASE-D ACTIVATION; NITRIC-OXIDE PRODUCTION; ARACHIDONIC-ACID; BLOOD-PRESSURE; SMOOTH-MUSCLE; OMEGA-HYDROXYLASE; ENDOTHELIAL DYSFUNCTION;
D O I
10.1097/MNH.0000000000000302
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose of review 20-Hydroxyeicosatetraenoic acid (20-HETE) is a potent vasoactive eicosanoid and a key constituent of the microcirculation. Its effects on vascular function are multifaceted and include stimulation of smooth muscle, contractility, migration, and proliferation, as well as endothelial cell dysfunction and inflammation. Such effects have significant implications with regard to the control of vascular homeostasis and pathophysiology. The clinical relevance of 20-HETE is highlighted by recent studies linking 20-HETE and its biosynthetic enzymes to the development of hypertension, stroke, and myocardial infarction. Recent findings This article presents past and recent findings that focus on the role of 20-HETE in the regulation of the vasculature in health and disease and the implication of its actions on endothelial and vascular smooth muscle cells to the pathogenesis of hypertension and stroke. Summary To date clinical studies corroborated animal studies in that they place 20-HETE as a significant contributor to the pathogenesis of cardiovascular diseases. Consequently, uncovering 20-HETE effects in the vasculature along with understanding its mechanism of action provide a strong basis for the development of novel therapeutic strategies to prevent vascular/end organ damage in these diseases.
引用
收藏
页码:74 / 82
页数:9
相关论文
共 50 条
  • [41] Targeting 20-Hydroxyeicosatetraenoic Acid in Rofecoxib-induced Cerebrovascular Damage
    Wang, Mong-Heng
    Weng, Jing
    Ergul, Adviye
    HYPERTENSION, 2016, 68
  • [42] 20-Hydroxyeicosatetraenoic acid is not associated with circulating insulin in lean to overweight humans
    Ward, Natalie C.
    Hodgson, Jonathan M.
    Puddey, Ian B.
    Beilin, Lawrence J.
    Croft, Kevin D.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2006, 74 (02) : 197 - 200
  • [43] 20-HYDROXYEICOSATETRAENOIC ACID IS AN ENDOTHELIUM-DEPENDENT VASOCONSTRICTOR IN RABBIT ARTERIES
    ESCALANTE, B
    OMATA, K
    SESSA, W
    LEE, SG
    FALCK, JR
    SCHWARTZMAN, ML
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 235 (01) : 1 - 7
  • [44] 20-Hydroxyeicosatetraenoic Acid and Angiotensin A Positive Feedback System to Cause Hypertension
    Imig, John D.
    HYPERTENSION, 2010, 56 (05) : 822 - 823
  • [45] Role of 20-hydroxyeicosatetraenoic acid in the renal and vasoconstrictor actions of angiotensin II
    Alonso-Galicia, M
    Maier, KG
    Greene, AS
    Cowley, AW
    Roman, RJ
    AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2002, 283 (01) : R60 - R68
  • [46] 20-HYDROXYEICOSATETRAENOIC ACID IS AN ENDOGENOUS VASOCONSTRICTOR OF CANINE RENAL ARCUATE ARTERIES
    MA, YH
    GEBREMEDHIN, D
    SCHWARTZMAN, ML
    FALCK, JR
    CLARK, JE
    MASTERS, BS
    HARDER, DR
    ROMAN, RJ
    CIRCULATION RESEARCH, 1993, 72 (01) : 126 - 136
  • [47] BIOLOGICAL-ACTIVITY AND METABOLISM OF 20-HYDROXYEICOSATETRAENOIC ACID IN THE HUMAN PLATELET
    HILL, E
    FITZPATRICK, F
    MURPHY, RC
    BRITISH JOURNAL OF PHARMACOLOGY, 1992, 106 (02) : 267 - 274
  • [48] 20-hydroxyeicosatetraenoic acid contributes to the increased renal vascular reactivity to phenylephrine in Zucker diabetic fat rats.
    Zhang, F
    Gealikman, O
    Togashi, N
    Laniado-Schwartzman, M
    Goligorsky, MS
    Nasjletti, A
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 621A - 621A
  • [49] 20-HYDROXYEICOSATETRAENOIC ACID IS AN ENDOTHELIUM-DEPENDENT VASOCONSTRICTOR IN RABBIT ARTERIES
    OMATA, K
    ESCALANTE, B
    SESSA, W
    LEE, SG
    FALCK, JR
    SCHWARTZMAN, ML
    HYPERTENSION, 1990, 16 (03) : 333 - 333
  • [50] 20-hydroxyeicosatetraenoic acid causes endothelial dysfunction via eNOS uncoupling
    Cheng, Jennifer
    Ou, Jing-Song
    Singh, Harpreet
    Falck, John R.
    Narsimhaswamy, Dubasi
    Pritchard, Kirkwood A.
    Schwartzman, Michal Laniado
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2008, 294 (02): : H1018 - H1026